换一批Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group.
第一作者：
N,Xiros
第一单位：
Second Department of Internal Medicine, Propaedeutic and Research Institute, University General Hospital 'Attikon', University of Athens, Greece. nxiros@otenet.gr
作者：
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);脱氧胞苷(Deoxycytidine);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);希腊(Greece);人类(Humans);男(雄)性(Male);最大耐受剂量(Maximum Tolerated Dose);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);姑息疗法(Palliative Care);胰腺肿瘤(Pancreatic Neoplasms);预后(Prognosis);生活质量(Quality of Life);危险性评估(Risk Assessment);存活率分析(Survival Analysis);临终病人(Terminally Ill);治疗结果(Treatment Outcome)
DOI
10.1093/annonc/mdi160
PMID
15802284
发布时间
2022-12-07
- 浏览3
Annals of oncology
773-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
